Jupiter Life Line Hospitals Ltd

Jupiter Life Lin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jupiter Life Line Hospitals Ltd

₹ 1,341 0.13%
10 Sep 1:50 p.m.
jupiterhospital.com BSE: 543980 NSE: JLHL
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Business Profile[1] The company has been operating for over 15 years as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. They operate 1194 beds, and have 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023.

Website BSE NSE
  • Market Cap ₹ 8,795 Cr.
  • Current Price ₹ 1,341
  • High / Low ₹ 1,654 / 960
  • Stock P/E 54.6
  • Book Value ₹ 190
  • Dividend Yield 0.07 %
  • ROCE 22.2 %
  • ROE 17.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 53.0% CAGR over last 5 years

Cons

  • Stock is trading at 7.06 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
179 198 200 210 208 227 230 245 239
130 141 154 158 157 168 173 189 184
Operating Profit 49 57 46 52 51 59 57 56 56
OPM % 27% 29% 23% 25% 25% 26% 25% 23% 23%
2 2 2 4 5 5 8 11 8
Interest 7 7 7 7 8 9 1 1 1
Depreciation 7 7 7 7 8 8 8 7 8
Profit before tax 37 46 34 42 41 48 56 59 55
Tax % 0% 21% 79% 36% 25% 25% 25% 27% 26%
37 36 7 27 30 36 42 43 41
EPS in Rs 7.31 7.10 1.28 4.73 5.39 5.51 6.44 6.58 6.20
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
320 398 463 461 657 787 911 942
266 333 380 392 498 583 687 714
Operating Profit 54 65 83 69 159 204 223 228
OPM % 17% 16% 18% 15% 24% 26% 25% 24%
5 2 2 4 4 11 30 32
Interest 16 24 26 28 29 28 19 11
Depreciation 20 24 26 27 28 29 31 31
Profit before tax 24 20 33 18 106 159 204 218
Tax % -25% 8% 10% 5% 20% 33% 25%
30 18 30 17 85 107 152 162
EPS in Rs 5.88 3.57 5.83 3.26 16.65 18.97 23.18 24.73
Dividend Payout % 8% 0% 0% 0% 0% 0% 4%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 25%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: 53%
3 Years: 109%
TTM: 57%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 19%
3 Years: 22%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 51 51 51 51 51 57 66
Reserves 147 162 186 202 276 409 1,180
210 252 263 262 322 298 0
63 71 94 100 106 123 115
Total Liabilities 470 537 594 615 755 885 1,361
379 431 435 426 465 476 477
CWIP 28 12 10 13 14 16 61
Investments 1 2 2 65 71 95 111
63 92 146 109 205 297 711
Total Assets 470 537 594 615 755 885 1,361

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
43 46 75 113 142 184 110
-43 -58 -43 -78 -68 -130 -256
1 16 -32 -23 10 -23 311
Net Cash Flow 1 3 -1 12 84 31 164

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 20 24 35 16 15 19 19
Inventory Days 60 46 64 45 38 42 39
Days Payable 224 168 268 192 155 169 116
Cash Conversion Cycle -144 -98 -169 -132 -101 -108 -59
Working Capital Days 11 18 44 4 -4 -16 -7
ROCE % 10% 12% 9% 23% 27% 22%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2023Dec 2023Mar 2024Jun 2024
40.91% 40.91% 40.91% 40.91%
4.62% 3.96% 4.17% 6.06%
12.69% 13.92% 14.16% 13.85%
41.80% 41.19% 40.76% 39.18%
No. of Shareholders 54,78239,34835,10735,797

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls